Neuroprotective Potentials of Panax Ginseng Against Alzheimer's Disease: A Review of Preclinical and Clinical Evidences.

Front Pharmacol

Jilin Ginseng Academy, Key Laboratory of Active Substances and Biological Mechanisms of Ginseng Efficacy, Ministry of Education, Jilin Provincial Key Laboratory of Bio-Macromolecules of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.

Published: June 2021

Alzheimer's disease (AD), a neurodegenerative disorder, is a major health concern in the increasingly aged population worldwide. Currently, no clinically effective drug can halt the progression of AD. C.A. Mey is a well-known medicinal plant that contains ginsenosides, gintonin, and other components and has neuroprotective effects against a series of pathological cascades in AD, including beta-amyloid formation, neuroinflammation, oxidative stress, and mitochondrial dysfunction. In this review, we summarize the effects and mechanisms of these major components and formulas containing in neuronal cells and animal models. Moreover, clinical findings regarding the prevention and treatment of AD with or its formulas are discussed. This review can provide new insights into the possible use of ginseng in the prevention and treatment of AD.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206566PMC
http://dx.doi.org/10.3389/fphar.2021.688490DOI Listing

Publication Analysis

Top Keywords

alzheimer's disease
8
prevention treatment
8
neuroprotective potentials
4
potentials panax
4
panax ginseng
4
ginseng alzheimer's
4
disease review
4
review preclinical
4
preclinical clinical
4
clinical evidences
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!